ArticleCureus2022

A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges.

Hitesh Gurjar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.